Prevalence, determinants and attitude towards herbal medicine use in the first trimester of pregnancy in Cameroon: A survey in 20 hospitals.
Journal
PLOS global public health
ISSN: 2767-3375
Titre abrégé: PLOS Glob Public Health
Pays: United States
ID NLM: 9918283779606676
Informations de publication
Date de publication:
2022
2022
Historique:
received:
08
04
2022
accepted:
04
08
2022
entrez:
24
3
2023
pubmed:
25
3
2023
medline:
25
3
2023
Statut:
epublish
Résumé
To examine the prevalence, determinants and attitude towards herbal medication (HM) use in the first trimester of pregnancy in Cameroon women. Between March to August 2015, we surveyed 795 pregnant women attending 20 randomly selected urban or rural hospitals in South West Cameroon on first trimester orthodox medication (OM) and HM use. Data was obtained by interviews using structured questionnaires. First trimester HM use was reported by 293 (36∙9%) women, 76% of whom used it in combination with OM. The most frequent indication for taking HM was prevention/treatment of anaemia (26∙3%). The HM were usually self-prescribed (33∙3%) or by family (56∙2%), and obtained from the woman's own garden (69∙3%). Twenty percent of women believed that HM was always safe to take in pregnancy, compared to 69.3% for OM. Intake of HM was significantly influenced by women's opinion on OM or HM safety-the odds of taking HM was 3 time higher among women who were unsure about the safety of OM (AOR: 3∙0, 95%CI = 1∙5-6∙1), while women who thought HM were never safe or who were unsure about its safety, were 91% or 84% respectively less likely to take HM compared to women who believed HM were always safe. We identified a high prevalence of HM use and concomitant use with OM, strongly influenced by women's perception of HM and OM safety. These findings indicate the need for WHO to specifically address safety in pregnancy in its policy to integrate traditional medicine use into existing healthcare systems in Africa.
Identifiants
pubmed: 36962818
doi: 10.1371/journal.pgph.0000726
pii: PGPH-D-22-00600
pmc: PMC10021538
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e0000726Informations de copyright
Copyright: © 2022 Leke et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Afr J Tradit Complement Altern Med. 2011;8(3):284-95
pubmed: 22468007
BMC Pregnancy Childbirth. 2018 Nov 20;18(1):450
pubmed: 30458752
J Obstet Gynaecol. 2005 Apr;25(3):235-40
pubmed: 16147724
Malar J. 2011 Mar 15;10 Suppl 1:S9
pubmed: 21411020
BMJ Glob Health. 2018 Oct 31;3(5):e000895
pubmed: 30483405
BMC Complement Altern Med. 2017 Aug 2;17(1):382
pubmed: 28768534
BMC Complement Altern Med. 2018 Jul 31;18(1):229
pubmed: 30064415
Front Pharmacol. 2020 Jun 09;11:866
pubmed: 32581815
Patient Prefer Adherence. 2017 Dec 20;12:1-8
pubmed: 29302186
BMC Complement Altern Med. 2018 May 25;18(1):166
pubmed: 29801482
BMC Complement Altern Med. 2013 Dec 12;13:355
pubmed: 24330413
Sci Rep. 2020 Apr 10;10(1):6219
pubmed: 32277158
J Ethnobiol Ethnomed. 2015 Oct 09;11:73
pubmed: 26453339
Can Fam Physician. 1984 Oct;30:2133-6
pubmed: 21279129
Phytother Res. 2005 Nov;19(11):919-23
pubmed: 16317644
Trop Med Infect Dis. 2018 Feb 11;3(1):
pubmed: 30274416
J Ethnopharmacol. 2018 Oct 5;224:297-313
pubmed: 29842963
Jundishapur J Nat Pharm Prod. 2014 Sep 15;9(4):e17368
pubmed: 25625049
Anthropol Med. 2011 Aug;18(2):245-55
pubmed: 21810040
Birth Defects Res A Clin Mol Teratol. 2012 Mar;94(3):123-8
pubmed: 22328359
Niger Med J. 2011 Jul;52(3):153-7
pubmed: 22083501
Afr J Reprod Health. 2011 Mar;15(1):85-93
pubmed: 21987942
Front Pharmacol. 2020 Jan 09;10:1483
pubmed: 31998122
BMC Complement Altern Med. 2019 Mar 15;19(1):65
pubmed: 30876425
Obstet Gynecol. 2019 May;133(5):920-932
pubmed: 30969204
Oman Med J. 2012 May;27(3):232-6
pubmed: 22811774
Eur J Contracept Reprod Health Care. 2014 Apr;19(2):108-20
pubmed: 24588339